More recent work published by, Halazun et al. to create the NYCA score has demonstrated that dynamic AFP response (NYCA score) to locoregional treatment is a better prognostic tool of HCC recurrence compared to static AFP, which only provides a pre-transplant AFP snapshot. This evidence concerns the gene AFP and hepatocellular carcinoma.